Sandrock Alfred — SEC Form 4 filings
SEC reporting owner CIK 1577061. 11 Form 4 filings on record with FilingPulse; latest filed 2026-04-03.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-16 to 2026-04-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 9 filings — 114,011 shares, $562,144 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 12,115 shares @ $9.86 ($119,454) in Voyager Therapeutics, Inc., filed 2024-04-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | President and CEO, Director | 11 | — | 9 legs · 114,011 sh · $562,144 | 6 |
Form 4 filings — Sandrock Alfred
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-03 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 11,511 @ $3.87 | EDGAR |
| 2026-02-26 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 14,197 @ $3.79 | EDGAR |
| 2026-02-20 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 11,732 @ $3.41 | EDGAR |
| 2026-02-11 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 12,192 @ $3.78 | EDGAR |
| 2026-02-10 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 86,250 @ $0 · Grant/award (A): 402,500 (derivative) @ $0 | EDGAR |
| 2025-04-04 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 10,885 @ $3.43 | EDGAR |
| 2025-02-24 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 11,702 @ $4.24 · Grant/award (A): 145,000 @ $0 · Grant/award (A): 290,000 (derivative) @ $0 | EDGAR |
| 2025-02-12 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 16,644 @ $4.45 | EDGAR |
| 2024-04-03 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 12,115 @ $9.86 | EDGAR |
| 2024-02-22 | 4 | Voyager Therapeutics, Inc. (VYGR) | Sale (S): 13,033 @ $7.46 | EDGAR |
| 2024-02-16 | 4 | Voyager Therapeutics, Inc. (VYGR) | Grant/award (A): 130,000 @ $0 · Grant/award (A): 260,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1577061 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →